Search

everythinglearnresearchcommunity

for

Search:↓

Ayurvedic Rasayan formulations like Chyawanprash may help manage post-COVID symptoms by boosting immunity.

Women are more likely to have long-term post-COVID symptoms than men.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

70.7% of patients had long-COVID symptoms like fatigue, cough, and brain fog three months after recovery.

Effective vaccines and treatments are crucial for long-term COVID-19 control.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Tamarix aphylla may be effective for various medical conditions, but more research is needed to confirm its safety and effectiveness.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

Long COVID is a complex condition with many symptoms and unknowns, needing more research.

Antiandrogens don't help with COVID-19 and aren't recommended.

Genetic differences affect how people respond to COVID-19.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Long COVID is a serious, long-lasting illness that needs more recognition and support.

Thrombophilic conditions may worsen Long COVID symptoms due to increased blood clotting.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Gender and social factors, not just biology, affect COVID-19 death rates.

Many COVID-19 survivors, especially women, experience hair loss and skin color changes, needing specific post-recovery care.

Valproic acid can cause low platelet counts, especially at high doses or in elderly patients.

CA-MRSA is a growing health issue needing new treatments and better hygiene to prevent spread.